Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis
Introduction Pathogenesis of atopic dermatitis (AD) is complex and includes several aspects, such as genetics and environmental exposure. Recently, several research studies have highlighted the effect of oxidative stress (OS) in different dermatological diseases such as psoriasis, AD, and alopecia a...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-05-01
|
| Series: | Journal of the Egyptian Women’s Dermatologic Society |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jewd.jewd_94_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850233307472592896 |
|---|---|
| author | Iman M. Abdelmeniem Aliaa I. Ismail Naglaa F. Agamia Nesrine A. Helaly Hassan Mamdouh Mohamed H. AbouHadeed Dalia I. Halwag |
| author_facet | Iman M. Abdelmeniem Aliaa I. Ismail Naglaa F. Agamia Nesrine A. Helaly Hassan Mamdouh Mohamed H. AbouHadeed Dalia I. Halwag |
| author_sort | Iman M. Abdelmeniem |
| collection | DOAJ |
| description | Introduction
Pathogenesis of atopic dermatitis (AD) is complex and includes several aspects, such as genetics and environmental exposure. Recently, several research studies have highlighted the effect of oxidative stress (OS) in different dermatological diseases such as psoriasis, AD, and alopecia areata.
Objective
To investigate the role of human advanced glycation end products (AGEs) and human advanced oxidation protein products (AOPPs) as markers of OS and inflammation in patients with AD.
Patients and methods
In the present case control study, serum levels of human AGEs and human AOPPs were measured in 30 patients with AD and in 30 controls.
Results
The level of OS markers was significantly higher in patients compared with controls (P<0.001). Patients with severe AD had significantly higher levels of OS markers compared with patients with moderate AD (P=0.020 and 0.025, respectively). Both can significantly predict the severity of AD with high sensitivity and specificity.
Conclusion
Human AGEs and human AOPPs function as useful markers of OS, and are elevated in patients with AD, and can be used for assessing disease severity. |
| format | Article |
| id | doaj-art-cba427a7d04f41c886393153df437eb3 |
| institution | OA Journals |
| issn | 2090-2565 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of the Egyptian Women’s Dermatologic Society |
| spelling | doaj-art-cba427a7d04f41c886393153df437eb32025-08-20T02:02:57ZengWolters Kluwer Medknow PublicationsJournal of the Egyptian Women’s Dermatologic Society2090-25652025-05-0122212813410.4103/jewd.jewd_94_24Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitisIman M. AbdelmeniemAliaa I. IsmailNaglaa F. AgamiaNesrine A. HelalyHassan MamdouhMohamed H. AbouHadeedDalia I. HalwagIntroduction Pathogenesis of atopic dermatitis (AD) is complex and includes several aspects, such as genetics and environmental exposure. Recently, several research studies have highlighted the effect of oxidative stress (OS) in different dermatological diseases such as psoriasis, AD, and alopecia areata. Objective To investigate the role of human advanced glycation end products (AGEs) and human advanced oxidation protein products (AOPPs) as markers of OS and inflammation in patients with AD. Patients and methods In the present case control study, serum levels of human AGEs and human AOPPs were measured in 30 patients with AD and in 30 controls. Results The level of OS markers was significantly higher in patients compared with controls (P<0.001). Patients with severe AD had significantly higher levels of OS markers compared with patients with moderate AD (P=0.020 and 0.025, respectively). Both can significantly predict the severity of AD with high sensitivity and specificity. Conclusion Human AGEs and human AOPPs function as useful markers of OS, and are elevated in patients with AD, and can be used for assessing disease severity.https://journals.lww.com/10.4103/jewd.jewd_94_24atopic dermatitisglycationoxidative stress |
| spellingShingle | Iman M. Abdelmeniem Aliaa I. Ismail Naglaa F. Agamia Nesrine A. Helaly Hassan Mamdouh Mohamed H. AbouHadeed Dalia I. Halwag Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis Journal of the Egyptian Women’s Dermatologic Society atopic dermatitis glycation oxidative stress |
| title | Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis |
| title_full | Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis |
| title_fullStr | Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis |
| title_full_unstemmed | Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis |
| title_short | Estimation of oxidative stress markers: human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis |
| title_sort | estimation of oxidative stress markers human advanced glycation end products and human advanced oxidation protein products in patients with atopic dermatitis |
| topic | atopic dermatitis glycation oxidative stress |
| url | https://journals.lww.com/10.4103/jewd.jewd_94_24 |
| work_keys_str_mv | AT imanmabdelmeniem estimationofoxidativestressmarkershumanadvancedglycationendproductsandhumanadvancedoxidationproteinproductsinpatientswithatopicdermatitis AT aliaaiismail estimationofoxidativestressmarkershumanadvancedglycationendproductsandhumanadvancedoxidationproteinproductsinpatientswithatopicdermatitis AT naglaafagamia estimationofoxidativestressmarkershumanadvancedglycationendproductsandhumanadvancedoxidationproteinproductsinpatientswithatopicdermatitis AT nesrineahelaly estimationofoxidativestressmarkershumanadvancedglycationendproductsandhumanadvancedoxidationproteinproductsinpatientswithatopicdermatitis AT hassanmamdouh estimationofoxidativestressmarkershumanadvancedglycationendproductsandhumanadvancedoxidationproteinproductsinpatientswithatopicdermatitis AT mohamedhabouhadeed estimationofoxidativestressmarkershumanadvancedglycationendproductsandhumanadvancedoxidationproteinproductsinpatientswithatopicdermatitis AT daliaihalwag estimationofoxidativestressmarkershumanadvancedglycationendproductsandhumanadvancedoxidationproteinproductsinpatientswithatopicdermatitis |